Scynexis (SCYX) Cash from Financing Activities (2013 - 2026)

Scynexis (SCYX) reported Cash from Financing Activities of $24.0 million for Q1 2026, up 270.68% on a YoY basis from $6.5 million in Q1 2025, and up 21002.61% quarter-over-quarter from -$115000.0 in Q4 2025.

Scynexis (SCYX) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Scynexis has reported Cash from Financing Activities for 14 years, with the latest figure at $24.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 270.68% year-over-year to $24.0 million; the trailing twelve-month figure through Mar 2026 stood at $24.0 million (up 268.58% YoY), and the FY2025 full-year result was -$14.2 million, down 10094.24% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $24.0 million, up from -$115000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $42.1 million in Q2 2022, with the low at -$36.6 million in Q2 2023.
  • Historically, Cash from Financing Activities has averaged $1.5 million across 5 years, with a median of $3500.0 in 2023.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 9569.01% — and 2025, when it plunged 93793.33%.
  • Scynexis' Cash from Financing Activities stood at -$183000.0 in 2022, then grew by 26.23% to -$135000.0 in 2023, then dropped by 14.81% to -$155000.0 in 2024, then increased by 25.81% to -$115000.0 in 2025, then jumped by 21002.61% to $24.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $24.0 million (Q1 2026), -$115000.0 (Q4 2025), and $29000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Scynexis 225.23 Mn 165.97 Mn - 24.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.04 Mn
Mar 31, 2026 24.04 Mn
Dec 31, 2025 -115,000.00
Dec 31, 2025 -115,000.00
Sep 30, 2025 29,000.00
Sep 30, 2025 29,000.00
Mar 31, 2025 -14.08 Mn
Mar 31, 2025 -14.08 Mn
Dec 31, 2024 -155,000.00
Dec 31, 2024 -155,000.00
Sep 30, 2024 31,000.00
Sep 30, 2024 31,000.00
Mar 31, 2024 -15,000.00
Mar 31, 2024 -15,000.00
Dec 31, 2023 -135,000.00
Dec 31, 2023 -135,000.00
Sep 30, 2023 34,000.00
Sep 30, 2023 34,000.00
Jun 30, 2023 -36.64 Mn
Jun 30, 2023 -36.64 Mn